Before a Trump executive order, employers could not provide free or subsidized insulin to their diabetic employees without sacrificing the employees’ right to have a Health Savings Account. This meant that employees had to spend their entire health insurance deductible out of pocket before any employer cost sharing took effect. The Trump administration’s change leaves employers and employees free to engage in the kind of cost-sharing arrangements that make economic and health care sense.
House Democrats apparently can’t abide so much freedom of choice. A new bill would restrict the employees’ share of insulin costs to $35 a month – regardless of workplace preferences and market conditions.
What would the bill do for the uninsured? Nothing.